Skip to main content
. 2018 Apr 5;35(1):29–34. doi: 10.1055/s-0038-1636518

Fig. 1.

Fig. 1

( a ) An 82-year-old woman with a solitary tumor in the right lobe measuring 4.5 cm × 3.3 cm (arrow). This patient was treated on a clinical trial with capecitabine and radioembolization. ( b ) CT 5 months later demonstrated a reduction in bidimensional size to 1.3 cm × 1.3 cm (arrow). This patient had isolated liver metastases and remained free of extrahepatic disease 666 days after the first Y90 treatment.